Does Semaglutide Cause Hair Loss?
Semaglutide (Ozempic, Wegovy, Rybelsus) does not list hair loss as a direct side effect in clinical trials or FDA labeling. However, some users report it, often linked to rapid weight loss rather than the drug itself. Weight loss exceeding 1-2 pounds per week can trigger telogen effluvium, a temporary shedding where hair follicles enter a resting phase.[1][2]
Why Do People Experience Hair Loss on Semaglutide?
Reports stem from real-world use, not controlled studies. A 2024 analysis of FDA adverse event data found 1,349 hair loss cases among semaglutide users, compared to 65 for tirzepatide (Mounjaro/Zepbound). This rate is low (about 0.05% of reports) and may reflect higher semaglutide prescriptions or self-reporting bias. Stress from dieting, calorie restriction, or nutritional deficits (protein, iron, biotin) during weight loss amplifies it.[3][4]
How Common Is It and Who Gets It?
Hair loss affects 3-6% of rapid weight loss cases generally, regardless of drug. Women in their 30s-50s on GLP-1 agonists like semaglutide report it most, per patient forums and dermatologist surveys. It's usually diffuse thinning, not bald patches, starting 2-4 months into treatment.[5]
How Long Does Semaglutide-Related Hair Loss Last?
Telogen effluvium resolves in 3-6 months after weight stabilizes or nutrition improves. Hair regrows fully for most without stopping the drug. Persistent cases may signal unrelated issues like thyroid problems or androgenetic alopecia.[2][6]
Can You Prevent or Treat It While on Semaglutide?
Maintain 1.2-1.6g protein per kg body weight daily, plus iron, zinc, and biotin supplements if deficient (test levels first). Minoxidil (topical) helps regrowth; consult a doctor. Slow weight loss to under 1% body weight weekly reduces risk. No evidence semaglutide worsens it beyond weight effects.[1][4]
What Do Dermatologists Say About GLP-1 Drugs and Hair?
Experts like Dr. Marisa Garshick note it's "weight loss shedding," not a drug class effect. A 2023 study in JAAD found no increased alopecia risk in semaglutide trials versus placebo. Switch to slower-titration GLP-1s or add-ons like tirzepatide if concerned, but evidence favors continuation with support.[5][7]
Compared to Other Weight Loss Drugs
| Drug | Hair Loss Reports | Notes |
|------|-------------------|-------|
| Semaglutide | Low (0.05%) | Tied to rapid loss [3] |
| Tirzepatide | Very low (0.01%) | Slower initial loss [3] |
| Phentermine | Moderate | Appetite suppression + stress [8] |
| Ozempic (semaglutide) vs. placebo | No difference | Trials show [7] |
[1] FDA Ozempic Label
[2] American Academy of Dermatology: Telogen Effluvium
[3] JAMA Dermatology: GLP-1 Alopecia Reports
[4] Cleveland Clinic: Weight Loss and Hair
[5] Healthline: Ozempic Hair Loss
[6] Mayo Clinic: Hair Loss Causes
[7] JAAD: Semaglutide Safety
[8] Drugs.com: Phentermine Side Effects